US Drug Recall Register
Class III · Low risk Terminated Initiated Dec 9, 2014 (12 years ago)

sulfur8

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed pH specification: Product pH test value of 5.72 failed to meet its product specification of 6.0 to 7.5.

What was recalled

sulfur8(R) medicated anti-dandruff conditioner, dandruff treatment for Braids, spray, Active Ingredient: Salicylic Acid, 2%, 12 FL OZ (356ml) spray bottle, OTC, Made in the U.S.A. J. Strickland & Co., OLIVE BRANCH, MS 38654 UPC: 0 7561044510 7

Recalling firm
J. Strickland and Co
Origin
MS, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0318-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Salicylic recalls

See all
Class II · Moderate risk Ongoing

Blemish Spot Treatment

Reason Failed Stability Specifications

Island Kinetics, Inc. d.b.a. CoValence Laboratories D-0487-2026
Class II · Moderate risk Terminated

Kingskin

Reason CGMP Deviations

Kenil Healthcare Private Limited NDC 55758-423-15 D-0424-2025
Class II · Moderate risk Ongoing

La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System

Reason cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.

L'Oreal USA D-0418-2025
Class II · Moderate risk Terminated

Blemfree All Day Lotion

Reason CGMP Deviations: Manufactured without following Current Good Manufacturing Practises.

Equibal Inc NDC 53228-002-01 D-0591-2024
Class II · Moderate risk Completed

Gordofilm Wart Remover

Reason cGMP Deviations

Dercher Enterprises, Inc., DBA Gordon Laboratories NDC 10481-3009-01 D-0495-2024